Don't Rely on Anti-Xa Levels to Verify LMWH Efficacy or Safety

We're getting questions about how to dose low-molecular-weight heparin (LMWH) for venous thromboembolism in obesity and renal impairment....

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals